Kurser indlæses...
Prognose
Vi har ingen analytikerdata for denne virksomhed.
Nyheder Til nyhedsfeedet
Growthpoint raises dividend for 2026, warns of weaker growth in 2027
Growthpoint increased distributable earnings per share by 4.3% to 152.6 cents and raised the dividend for 2026 by 7.4% to 133 cents. Net asset value per share rose by 3.8%, the loan-to-value ratio improved to 38.7%; net rental income in South Africa grew like-for-like by 4.4%. For 2027 management now forecasts only 1–3% dividend growth, citing the weak office market in Gauteng, slower reinvestment after disposals and higher financing costs as headwinds. » Mere på de.investing.com
Growthpoint sells entire 14.2% stake in NewRiver REIT for £50.5 million
Growthpoint Properties Limited has completed the sale of its entire 14.2% stake in NewRiver REIT plc, disposing of 67.4 million ordinary shares at 75 pence each for gross proceeds of £50.5 million. The placing was conducted, according to the announcement, with strong interest from existing and new investors; Panmure Liberum Limited acted as sole bookrunner and settlement is scheduled for 15 August 2025. NewRiver REIT itself will receive no proceeds from the transaction, as it was a sale of Growthpoint’s existing shares. » Mere på de.investing.com
Growthpoint plans sale of around 47.7 million NewRiver shares at 75p each
Growthpoint Properties Limited will sell approximately 47.7 million ordinary shares of NewRiver REIT plc in an accelerated bookbuild at 75 pence per share, representing most of its previous 14.2% holding. NewRiver has said it intends to buy back up to around 47.7 million of the placed shares; Panmure Liberum is sole bookrunner and NewRiver will receive no proceeds from the secondary placing. The announcement was published as inside information under the UK Market Abuse Regulations, and the final placing result will be announced after the bookbuild is complete. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 327,8 mio. | - |
| Bruttofortjeneste | 181,17 mio. | - |
| Nettoresultat | 275,82 mio. | - |
| EBITDA | 451,16 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 2,85 mia. € |
Antal aktier | 33,86 mio. |
Højeste/laveste i 52 uger | 102,27 € - 82,05 € |
Udbytteafkast | 8,34 % |
Udbytte TTM | 0,0709 € |
Beta | 0,58 |
P/E (PE Ratio) | 7,03 |
PEG (PEG Ratio) | 0,16 |
K/I (PB Ratio) | 0,76 |
P/S (PS Ratio) | 4,11 |
Virksomhedsprofil
Growthpoint er den største primære JSE-noterede REIT i Sydafrika med en kvalitetsportefølje på 440 direkte ejede ejendomme i Sydafrika (RSA) med en værdi på R73,4 mia., herunder fire hospitaler og ét medicinsk center med en værdi på R2,6 mia., ejet af Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint har en aktieandel på 61,8 % i GHPH. Vi har en 62,2 % andel i ASX-noterede Growthpoint Properties Australia Limited (GOZ), som ejer 58 ejendomme i Australien med en værdi på R51,8 mia., og en 52,1 % andel i LSE-noterede Capital & Regional Plc (C&R), som ejer syv ejendomme i Storbritannien med en værdi på R14,8 mia.
| Navn | GROWTHPOINT PPTYS |
| CEO | Estienne Konrad de Klerk |
| Hjemsted | Sandton,
gp Sydafrika |
| Websted | |
| Børsnotering | 11.04.2018 |
| Medarbejdere | 634 |
Deep Dive
Tickersymboler
| Børs | Symbol |
|---|---|
Jnb | GRT.JO |
Pnk | GWWTF |
Frankfurt | G5JA.F |
München | G5JA.MU |